세계의 정맥주사 용액 시장 규모 조사 및 예측 : 용액 구성, 유형 및 지역별 분석(2022-2029년)

Global Intravenous Solutions Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's bloodstream through a vein. They are commonly used in hospitals, clinics, and other medical settings to provide hydration, medications, nutrients, or other therapeutic agents to patients who are unable to take these substances orally. IV solutions can contain various combinations of water, electrolytes, sugars, vitamins, and medications, depending on the patient's needs. They come in different concentrations and types, such as isotonic, hypotonic, and hypertonic, which determine their effect on the body's fluid balance. The key factor driving the market growth is rise in prevalence of malnutrition, and advancements and new innovations in the products for patient convenience that anticipated to support the market growth during forecast period.

Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.

Major market players included in this report are:

• Amanta Healthcare Ltd.
• Axa Parenterals Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Dickinson and Company
• Eurolife Healthcare Pvt Ltd.
• Fresenius Kabi AG
• Grifols S.A
• Henry Schein Inc.
• ICU Medical, Inc.

Recent Developments in the Market:

• In February 2022, B. Braun Medical has been granted approval by the US FDA to begin manufacturing IV saline solutions at its new plant in Daytona Beach, Florida.

Global Intravenous Solutions Market Report Scope:

• Historical Data: 2019-2020-2021
• Base Year for Estimation: 2021
• Forecast period: 2022-2029
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Type, Solution Composition, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

By Solution Composition:

• Saline
• Carbohydrates
• Vitamins and Minerals
• Other Solution Compositions

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Intravenous Solutions Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Intravenous Solutions Market, by Type, 2019-2029 (USD Billion)
  • 1.2.3. Intravenous Solutions Market, by Solution Composition, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Intravenous Solutions Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Intravenous Solutions Market Dynamics

• 3.1. Intravenous Solutions Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rise in prevalence of malnutrition
    • 3.1.1.2. Advancements and new innovations in the products for patient convenience
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of experienced healthcare professionals
    • 3.1.2.2. Complications of intravenous administration therapy
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing geriatric population

Chapter 4. Global Intravenous Solutions Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Intravenous Solutions Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Intravenous Solutions Market by Type, Performance - Potential Analysis
• 6.3. Global Intravenous Solutions Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Intravenous Solutions Market, Sub Segment Analysis
  • 6.4.1. Total Parenteral Nutrition
  • 6.4.2. Peripheral Parenteral Nutrition

Chapter 7. Global Intravenous Solutions Market, by Solution Composition

• 7.1. Market Snapshot
• 7.2. Global Intravenous Solutions Market by Solution Composition, Performance - Potential Analysis
• 7.3. Global Intravenous Solutions Market Estimates & Forecasts by Solution Composition 2019-2029 (USD Billion)
• 7.4. Intravenous Solutions Market, Sub Segment Analysis
  • 7.4.1. Saline
  • 7.4.2. Carbohydrates
  • 7.4.3. Vitamins and Minerals
  • 7.4.4. Other Solution Compositions

Chapter 8. Global Intravenous Solutions Market, Regional Analysis

• 8.1. Intravenous Solutions Market, Regional Market Snapshot
• 8.2. North America Intravenous Solutions Market
  • 8.2.1. U.S. Intravenous Solutions Market
    • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Solution Composition breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Intravenous Solutions Market
• 8.3. Europe Intravenous Solutions Market Snapshot
  • 8.3.1. U.K. Intravenous Solutions Market
  • 8.3.2. Germany Intravenous Solutions Market
  • 8.3.3. France Intravenous Solutions Market
  • 8.3.4. Spain Intravenous Solutions Market
  • 8.3.5. Italy Intravenous Solutions Market
  • 8.3.6. Rest of Europe Intravenous Solutions Market
• 8.4. Asia-Pacific Intravenous Solutions Market Snapshot
  • 8.4.1. China Intravenous Solutions Market
  • 8.4.2. India Intravenous Solutions Market
  • 8.4.3. Japan Intravenous Solutions Market
  • 8.4.4. Australia Intravenous Solutions Market
  • 8.4.5. South Korea Intravenous Solutions Market
  • 8.4.6. Rest of Asia Pacific Intravenous Solutions Market
• 8.5. Latin America Intravenous Solutions Market Snapshot
  • 8.5.1. Brazil Intravenous Solutions Market
  • 8.5.2. Mexico Intravenous Solutions Market
  • 8.5.3. Rest of Latin America Intravenous Solutions Market
• 8.6. Rest of The World Intravenous Solutions Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Amanta Healthcare Ltd.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Axa Parenterals Ltd.
  • 9.2.3. B. Braun Melsungen AG
  • 9.2.4. Baxter International Inc.
  • 9.2.5. Dickinson and Company
  • 9.2.6. Eurolife Healthcare Pvt Ltd.
  • 9.2.7. Fresenius Kabi AG
  • 9.2.8. Grifols S.A
  • 9.2.9. Henry Schein Inc.
  • 9.2.10. ICU Medical, Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption